Supplement Scholar
Compound

Ubiquinol (CoQ10)

Buy on Amazon ↗

Affiliate link: we may earn a commission at no extra cost to you. Disclosures

Ubiquinol (CoQ10). Reduced active form of CoQ10 — preferred in adults over 40 and those with statin-induced depletion.

How it works. Already in reduced form — directly usable in the electron transport chain and as a lipid antioxidant.

What the research supports. 2 graded claims. Strongest: Higher plasma CoQ10 vs ubiquinone at equal dose in older adults (moderate).

How much to take. Typical dose: 100–200 mg.

Side effects and interactions. 1 medication interaction listed. Serious: Discontinue and seek medical advice if symptoms are severe, persistent, or include difficulty breathing.

Stacking. Pairs well with Omega-3, CoQ10, NAD+ precursor (NMN or NR).

Common forms. Available as Capsule or softgel, Powder, Sublingual or buccal, Liposomal liquid.

Key studies. 9 studies cited. The strongest are listed with links to PubMed.

Community. Experiences from people who have tried Ubiquinol (CoQ10). Anecdotes are not medical advice.

Ubiquinol (CoQ10). Reduced active form of CoQ10 — preferred in adults over 40 and those with statin-induced depletion.

Molecular structureC59H92O4 · 865.4 g/mol

What it is

Reduced active form of CoQ10 — preferred in adults over 40 and those with statin-induced depletion.

Food sources

Endogenously produced or biosynthesized moleculeStandardized pharmaceutical- or food-grade supplementCombined with cofactors that improve absorption or activity

Goals

How it works

Already in reduced form — directly usable in the electron transport chain and as a lipid antioxidant.

Pathways

  • ETC complex I–III shuttle
  • Lipid peroxidation defense

Effects

  • +Higher plasma CoQ10 vs ubiquinone at equal dose in older adults supports
  • +heart failure outcomes (Q-SYMBIO) supports

What the research supports

Higher plasma CoQ10 vs ubiquinone at equal dose in older adultsmoderate
Improves heart failure outcomes (Q-SYMBIO)moderate

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Typical dose
100–200 mg
TimingConsistent daily timing recommended; split larger doses if GI tolerance is a concern.
With foodWith fat
Best formMost evidence is based on the capsule or softgel form.
Shop Ubiquinol (CoQ10) on Amazon ↗

As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.

Side effects & interactions

Common side effects

  • Ubiquinol (CoQ10) is generally well-tolerated at evidence-based doses
  • Mild GI discomfort (nausea, loose stools, or bloating) possible at higher intakes
  • Headache or transient fatigue reported by a small fraction of users

Serious

  • Discontinue and seek medical advice if symptoms are severe, persistent, or include difficulty breathing

Medication interactions

Prescription medications (general)minor

Always disclose Ubiquinol (CoQ10) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • Omega-3Anti-inflammatory cardiovascular synergy.
  • CoQ10Supports mitochondrial energetics in cardiac tissue.
  • NAD+ precursor (NMN or NR)Complementary mitochondrial and sirtuin support.

Common forms

  • Capsule or softgel
  • Powder
  • Sublingual or buccal
  • Liposomal liquid

Key studies

9 studies cited in total.

PubMed: Ubiquinol (CoQ10) — Higher plasma CoQ10 vs ubiquinone at equal dose in older adults ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Ubiquinol (CoQ10) and "Higher plasma CoQ10 vs ubiquinone at equal dose in older adults". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Ubiquinol (CoQ10) — Improves heart failure outcomes ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Ubiquinol (CoQ10) and "Improves heart failure outcomes". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Ubiquinol (CoQ10) — randomized controlled trial ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Ubiquinol (CoQ10) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

Discussion

Loading discussion…